CD4 and rheumatoid arthritis: The numbers of circulating Th1, Th2 or Th17 CD4+T-lymphocytes subsets in the early clinical stages of RA show two different profiles of cytokine producing CD4+ T-lymphocyte subsets associated to a response or not associated to the MTX treatment of the RA patients.